243 related articles for article (PubMed ID: 18609264)
21. The effect of tocilizumab on bone mineral density in patients with methotrexate-resistant active rheumatoid arthritis.
Kume K; Amano K; Yamada S; Kanazawa T; Ohta H; Hatta K; Amano K; Kuwaba N
Rheumatology (Oxford); 2014 May; 53(5):900-3. PubMed ID: 24441151
[TBL] [Abstract][Full Text] [Related]
22. Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX®: a registry study of RA with osteoporosis/fracture.
Cheng TT; Yu SF; Su FM; Chen YC; Su BY; Chiu WC; Hsu CY; Chen JF; Ko CH; Lai HM
Arthritis Res Ther; 2018 Jan; 20(1):16. PubMed ID: 29382355
[TBL] [Abstract][Full Text] [Related]
23. Is bone turnover a determinant of bone mass in rheumatoid arthritis?
Cortet B; Flipo RM; Pigny P; Duquesnoy B; Boersma A; Marchandise X; Delcambre B
J Rheumatol; 1998 Dec; 25(12):2339-44. PubMed ID: 9858427
[TBL] [Abstract][Full Text] [Related]
24. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis.
López-Longo FJ; Oliver-Miñarro D; de la Torre I; González-Díaz de Rábago E; Sánchez-Ramón S; Rodríguez-Mahou M; Paravisini A; Monteagudo I; González CM; García-Castro M; Casas MD; Carreño L
Arthritis Rheum; 2009 Apr; 61(4):419-24. PubMed ID: 19333979
[TBL] [Abstract][Full Text] [Related]
25. Effect of cyclosporine A on bone density in female rheumatoid arthritis patients: results from a multicenter, cross-sectional study.
Mazzantini M; Di Munno O; Sinigaglia L; Bianchi G; Rossini M; Mela Q; Del Puente A; Frediani B; Cantatore F; Adami S
Clin Exp Rheumatol; 2007; 25(5):709-15. PubMed ID: 18078618
[TBL] [Abstract][Full Text] [Related]
26. Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritis.
Christensen AF; Lindegaard H; Hørslev-Petersen K; Hetland ML; Ejbjerg B; Stengaard-Pedersen K; Jacobsen S; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Tarp U; Pødenphant J; Østergaard M; Junker P
J Rheumatol; 2011 Aug; 38(8):1563-8. PubMed ID: 21572145
[TBL] [Abstract][Full Text] [Related]
27. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome.
Quinn MA; Gough AK; Green MJ; Devlin J; Hensor EM; Greenstein A; Fraser A; Emery P
Rheumatology (Oxford); 2006 Apr; 45(4):478-80. PubMed ID: 16287917
[TBL] [Abstract][Full Text] [Related]
28. In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density.
Rossini M; Viapiana O; Adami S; Fracassi E; Idolazzi L; Dartizio C; Povino MR; Orsolini G; Gatti D
Clin Exp Rheumatol; 2015; 33(1):77-83. PubMed ID: 25438096
[TBL] [Abstract][Full Text] [Related]
29. Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients.
Regueiro C; Ortiz AM; Boveda MD; Castañeda S; Gonzalez-Alvaro I; Gonzalez A
PLoS One; 2018; 13(8):e0202583. PubMed ID: 30118518
[TBL] [Abstract][Full Text] [Related]
30. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.
Korkmaz C; Us T; Kaşifoğlu T; Akgün Y
Clin Biochem; 2006 Oct; 39(10):961-5. PubMed ID: 16979149
[TBL] [Abstract][Full Text] [Related]
31. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
32. Anti-cyclic citrullinated peptides positivity rate in patients with familial Mediterranean fever.
Ceri M; Unverdi S; Altay M; Ureten K; Oztürk MA; Gönen N; Duranay M
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S58-61. PubMed ID: 20868572
[TBL] [Abstract][Full Text] [Related]
33. [Association between bone mineral density and erosive and destructive changes in patients with rheumatoid arthritis: preliminary results].
Petrova EV; Dydykina IS; Smirnov AV; Podvorotova MM; Taskina EA; Dydykina PS; Glukhova SI; Alekseeva LI; Nasonov EL
Ter Arkh; 2014; 86(5):10-7. PubMed ID: 25026797
[TBL] [Abstract][Full Text] [Related]
34. LRP5 gene polymorphisms and radiographic joint damage in rheumatoid arthritis patients.
Bernardes M; Durães C; Oliveira A; Martins MJ; Lucas R; Costa L; Pereira JG; Ramos I; Machado JC; Simões-Ventura F
Osteoporos Int; 2018 Oct; 29(10):2355-2368. PubMed ID: 30019084
[TBL] [Abstract][Full Text] [Related]
35. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Mathsson L; Mullazehi M; Wick MC; Sjöberg O; van Vollenhoven R; Klareskog L; Rönnelid J
Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519
[TBL] [Abstract][Full Text] [Related]
36. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
[TBL] [Abstract][Full Text] [Related]
37. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
[TBL] [Abstract][Full Text] [Related]
38. [Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis].
Yang CL; Zhou YR; Zhou F; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1277-9. PubMed ID: 17715048
[TBL] [Abstract][Full Text] [Related]
39. Measurement of hand bone mineral density in early rheumatoid arthritis using dual energy X-ray absorptiometry.
Hill CL; Schultz CG; Wu R; Chatterton BE; Cleland LG
Int J Rheum Dis; 2010 Aug; 13(3):230-4. PubMed ID: 20704619
[TBL] [Abstract][Full Text] [Related]
40. Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis.
Güler-Yüksel M; Bijsterbosch J; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Ronday HK; Peeters AJ; de Jonge-Bok JM; Breedveld FC; Dijkmans BA; Allaart CF; Lems WF
Ann Rheum Dis; 2007 Nov; 66(11):1508-12. PubMed ID: 17456523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
